These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6137646

  • 1. Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children.
    Vesikari T, Isolauri E, Delem A, D'Hondt E, André FE, Zissis G.
    Lancet; 1983 Oct 08; 2(8354):807-11. PubMed ID: 6137646
    [Abstract] [Full Text] [Related]

  • 2. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
    Vesikari T, Kapikian AZ, Delem A, Zissis G.
    J Infect Dis; 1986 May 08; 153(5):832-9. PubMed ID: 3009634
    [Abstract] [Full Text] [Related]

  • 3. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
    Vesikari T, Isolauri E, D'Hondt E, Delem A, André FE, Zissis G.
    Lancet; 1984 May 05; 1(8384):977-81. PubMed ID: 6143964
    [Abstract] [Full Text] [Related]

  • 4. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML.
    Rev Infect Dis; 1989 May 05; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [Abstract] [Full Text] [Related]

  • 5. Trial of an attenuated bovine rotavirus vaccine (RIT 4237).
    Biryahwaho B.
    Lancet; 1987 Aug 08; 2(8554):344. PubMed ID: 2886814
    [No Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants.
    Maldonado Y, Hestvik L, Wilson M, Townsend T, O'Hare J, Wee S, Yolken R.
    J Pediatr; 1986 Dec 08; 109(6):931-5. PubMed ID: 3537248
    [Abstract] [Full Text] [Related]

  • 7. Review of rotavirus vaccine trials in Finland.
    Vesikari T, Joensuu J.
    J Infect Dis; 1996 Sep 08; 174 Suppl 1():S81-7. PubMed ID: 8752295
    [Abstract] [Full Text] [Related]

  • 8. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G, Ferrarini G, Rigolin F, Bogaerts H, André FE.
    Helv Paediatr Acta; 1986 Aug 08; 41(3):203-8. PubMed ID: 3019954
    [Abstract] [Full Text] [Related]

  • 9. Clinical trials of rotavirus vaccines.
    Vesikari T, Isolauri E, Ruuska T, Rautanen T.
    Ciba Found Symp; 1987 Aug 08; 128():218-37. PubMed ID: 3036442
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety of a low passage level bovine rotavirus candidate vaccine RIT 4256 in human adults and young infants.
    Vesikari T, Rautanen T, Isolauri E, Delem A, André FE.
    Vaccine; 1987 Jun 08; 5(2):105-8. PubMed ID: 3037812
    [Abstract] [Full Text] [Related]

  • 11. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain.
    Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, Andre FE.
    Vaccine; 1986 Dec 08; 4(4):233-6. PubMed ID: 3026106
    [Abstract] [Full Text] [Related]

  • 12. [Oral vaccination with live attenuated rotavirus].
    Escobar Castro H, Perdomo Giraldi M, Tamáriz-Martel Moreno A, Suárez Cortina L.
    An Esp Pediatr; 1988 Jun 08; 28(6):527-9. PubMed ID: 2848432
    [Abstract] [Full Text] [Related]

  • 13. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12.
    Bernstein DI, Smith VE, Sherwood JR, Schiff GM, Sander DS, DeFeudis D, Spriggs DR, Ward RL.
    Vaccine; 1998 Feb 08; 16(4):381-7. PubMed ID: 9607059
    [Abstract] [Full Text] [Related]

  • 14. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants.
    Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, Jobe O, Sillah H, Hayes R, M'Boge BH.
    Lancet; 1987 Jun 13; 1(8546):1342-5. PubMed ID: 2884455
    [Abstract] [Full Text] [Related]

  • 15. Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge.
    Zissis G, Lambert JP, Marbehant P, Marissens D, Lobmann M, Charlier P, Delem A, Zygraich N.
    J Infect Dis; 1983 Dec 13; 148(6):1061-8. PubMed ID: 6317767
    [Abstract] [Full Text] [Related]

  • 16. Clinical trials of live oral rotavirus vaccines: the Finnish experience.
    Vesikari T.
    Vaccine; 1993 Dec 13; 11(2):255-61. PubMed ID: 8382419
    [Abstract] [Full Text] [Related]

  • 17. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.
    Lanata CF, Black RE, del Aguila R, Gil A, Verastegui H, Gerna G, Flores J, Kapikian AZ, Andre FE.
    J Infect Dis; 1989 Mar 13; 159(3):452-9. PubMed ID: 2536789
    [Abstract] [Full Text] [Related]

  • 18. Epidemiologic background for the need of rotavirus vaccine in Finland. Preliminary experience of RIT 4237 strain of live attenuated rotavirus vaccine in adults.
    Vesikari T, Mäki M, Isolauri E.
    Dev Biol Stand; 1983 Mar 13; 53():229-36. PubMed ID: 6307778
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea.
    Vesikari T, Ruuska T, Delem A, André FE, Beards GM, Flewett TH.
    Acta Paediatr Scand; 1991 Feb 13; 80(2):173-80. PubMed ID: 1852084
    [Abstract] [Full Text] [Related]

  • 20. [Anti-rotavirus vaccinations].
    Schmitz J.
    Arch Pediatr; 1999 Sep 13; 6(9):979-84. PubMed ID: 10519034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.